Skip to main content

Table 1 Association between viral load, antiretroviral adherence profile and the adoption of COVID-19 pandemic preventive behaviour status among PLHIV during the first wave of the pandemic (N = 680)

From: Differences in adoption of COVID-19 pandemic related preventive behaviour by viral load suppression status among people living with HIV during the first wave of the pandemic

Variables

Total

N = 680

n (%)

Physical Distancing

Face mask

Handwashing

Work remotely

No

221(32.5%)

n (%)

Yes

459(67.5%)

n (%)

AOR; 95% CI; p value

No

99(14.6%)

n (%)

Yes

581(85.4%)

n (%)

AOR; 95% CI; p value

No

132(19.4%)

n (%)

Yes

548(80.6%)

n (%)

AOR; 95% CI; p value

No

540(79.4%)

n (%)

Yes

140 (20.6)

n (%)

AOR; 95% CI; p value

Viral load

             

Undetectable

Detectable

488 (71.8)

192 (28.2)

157 (32.2)

64 (33.3)

331 (67.8)

128 (66.7)

1

1.06; 0.72–1.55; p = 0.74

56 (11.5)

43 (22.4)

432 (88.5)

149 (77.6)

1

0.44; 0.28–0.69;p < 0.01

86 (17.6)

46 (24.0)

402 (82.4)

146 (76.0)

1

0.64; 0.42–0.97;p = 0.03

389 (79.7)

151 (78.6)

99 (20.3)

41 (21.4)

1

0.99; 0.64–1.53; p = 0.98

Adherence

             

to ART

No

Yes

151 (22.2)

529 (77.8)

53 (35.1)

168 (31.8)

98 (64.9)

361 (68.2)

1

1.04; 0.69–1.58; p = 0.83

23 (15.2)

76 (14.4)

128 (84.8)

453 (85.6)

1

0.99; 0.57–0.71;p = 0.98

30 (19.9)

102 (19.3)

121 (80.1)

427 (80.7)

1

1.11; 0.69–1.81;p = 0.65

107 (70.9)

433 (81.9)

44 (29.1)

96 (18.1)

1

0.60; 0.38–0.94; p = 0.02

Age

39.9 (11.3)

39.1 (11.6)

40.3 (11.2)

1.01; 1.00-1.03; p = 0.38

40.9 (11.3)

39.7 (11.3)

0.99; 0.97-1.00;p = 0.51

39.3 (10.1)

40.0 (11.6)

1.07; 0.98–1.02; p = 0.46

39.6 (11.6)

40.8 (10.3)

1.01; 0.99–1.03; p = 0.17

Sex

             

Male

Female

Intersex

Decline to answer

277 (40.8)

395 (58.1)

3 (0.4)

5 (0.7)

89 (32.1)

129 (32.7)

2 (66.7)

1 (20.0)

188 (67.9)

266 (67.3)

1 (33.3)

4 (80.0)

1

0.97; 0.69–1.38; p = 0.89

0.67; 0.04–9.71; p = 0.77

1.72; 0.18–15.82; p = 0.62

40 (14.4)

56 (14.2)

1 (33.3)

2 (40.0)

237 (85.6)

339 (85.8)

2 (66.7)

3 (60.0)

1

0.94; 0.59–0.48;p = 0.80

0.56; 0.03–0.87;p = 0.68

0.20; 0.03–0.29;p = 0.09

48 (17.3)

82 (20.8)

1 (33.3)

1 (20.0)

229 (82.7)

313 (79.2)

2 (66.7)

4 (80.0)

1

0.81; 0.54–1.22;p = 0.32

0.53; 0.03–7.87;p = 0.64

0.96; 0.10–8.94;p = 0.97

217 (78.3)

316 (80.0)

2 (66.7)

5 (100.0)

60 (21.7)

79 (20.0)

1 (33.3)

0 (0.0)

1

0.93; 0.63–1.39; p = 0.75

3.30; 0.22–49.46; p = 0.38

Not calculated (p = 0.99)

Educational level

             

No formal

Primary

Secondary

Tertiary

24 (3.5)

57 (8.4)

239 (35.1)

360 (52.9)

20 (83.3)

30 (52.6)

72 (30.1)

99 (27.5)

4 (16.7)

27 (47.4)

167 (69.9)

261 (72.5)

0.66; 0.02–0.20; p < 0.01

0.34; 0.19–0.60; p < 0.01

0.94; 0.65–1.36; p = 0.75

1

8 (33.3)

14 (24.6)

31 (13.0)

46 (12.8)

16 (66.7)

43 (75.4)

208 (87.0)

314 (87.2)

0,30; 0.11 − 0.79; p = 0,01

0.43; 0.21 − 0.87; p = 0.01

0.96; 0.58 − 1.59; p = 0.89

1

6 (25.0)

12 (21.1)

51 (21.3)

63 (17.5)

18 (75.0)

45 (78.9)

188 (78.7)

297 (82.5)

0.49; 0.17 − 1.39; p = 0.18

0.78; 0.38 − 1.60; p = 0.50

0.82; 0.53 − 1.26; p = 0.37

1

21 (87.5)

53 (93.0)

203 (84.9)

263 (73.1)

3 (12.5)

4 (7.0)

36 (15.1)

97 (26.9)

0.24; 0.06 − 0.89; p = 0.03

0.19; 0.06 − 0.55; p < 0,01

0.53; 0.34 − 0.82; p < 0,001

1

Depression

             

No

Yes

52 (81.2)

128 (18.8)

177 (32.1)

44 (34.4)

375 (67.9)

84 (65.6)

1

1.09; 0.70–1.69; p = 0.70

86 (15.6)

13 (10.2)

466 (84.4)

115 (89.8)

1

1.90; 0.99–3.68;p = 0.05

124 (22.5)

8 (6.3)

428 (77.5)

120 (93.7)

1

4.80; 2.24–10.27;p < 0.01

453 (82.1)

87 (68.0)

99 (17.9)

41 (32.0)

1

2.10; 1.33–3.31; p < 0.01

  1. *ART – Antiretroviral therapy